Millar, B C <br/><br/>
Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.  [electronic resource] 

 -  Journal of clinical pharmacy and therapeutics  Feb 2018 
 - 92-100 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2710 
<br/><br/><label>Standard No.: </label>10.1111/jcpt.12616  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aminophenols--therapeutic use<br/>Anti-Bacterial Agents--therapeutic use<br/>Cystic Fibrosis--drug therapy<br/>Cystic Fibrosis Transmembrane Conductance Regulator--genetics<br/>Female<br/>Humans<br/>Male<br/>Microbial Sensitivity Tests--methods<br/>Mutation--genetics<br/>Pseudomonas Infections--drug therapy<br/>Pseudomonas aeruginosa--drug effects<br/>Quinolones--therapeutic use<br/>Retrospective Studies<br/>Young Adult